Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23780594 | 0.77 | ALDH1A1 (0.37) | ALDH1A1HPGDKDM4EHTTL3MBTL1 | |
| SCHEMBL23780598 | 0.72 | ALDH1A1 (0.34) | ALDH1A1HPGDKDM4EHTTL3MBTL1 | |
| SCHEMBL23780596 | 0.67 | TDP1 (0.36) | ALDH1A1HPGDKDM4EHTTL3MBTL1 | |
| SCHEMBL27404855 | 0.61 | ALDH1A1 (0.62) | ALDH1A1HPGD | |
| SCHEMBL13581220 | 0.61 | ALDH1A1 (0.55) | ALDH1A1HPGD | |
| SCHEMBL16596421 | 0.61 | ALDH1A1 (0.57) | ALDH1A1HPGD | |
| SCHEMBL23780604 | 0.59 | LMNA (0.32) | — | |
| SCHEMBL16411544 | 0.59 | — | — | |
| SCHEMBL31464941 | 0.58 | MAPT (0.37) | THRATHRB | |
| SCHEMBL8448469 | 0.58 | ALDH1A1 (0.63) | ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685716-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2023-06-27 | — | — | US | disclosed |
| US-11685716-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2023-06-27 | — | — | US | disclosed |
| US-11685716-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2023-06-27 | — | — | US | disclosed |
| US-20220048857-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2022-02-17 | — | — | US | disclosed |
| US-11142497-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20210276950-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220048857-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | ING2, CCNA1, CCNI | ALDH1A1 2359/4885HPGD 2622/4885KDM4E 1983/4885 |
| US-11685716-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | ING2, CCNA1, CCNI | ALDH1A1 2359/4885HPGD 2622/4885KDM4E 1983/4885 |
| US-11142497-B2 | Plant growth inhibiting agent, and plant growth inhibiting method using same | ING2, CCNA1, CCNI | ALDH1A1 2359/4885HPGD 2622/4885KDM4E 1983/4885 |
| US-20210276950-A1 | PLANT GROWTH INHIBITING AGENT, AND PLANT GROWTH INHIBITING METHOD USING SAME | ING2, CCNA1, CCNI | ALDH1A1 2359/4885HPGD 2622/4885KDM4E 1983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.